Park Ha Biological Technology Co., Ltd.
BYAH
$1.05
$0.010.96%
NASDAQ
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 3.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 3.74% | |||
| Cost of Revenue | 0.00% | 43.34% | |||
| Gross Profit | 0.00% | 1.78% | |||
| SG&A Expenses | 0.00% | -74.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -72.71% | |||
| Operating Income | 0.00% | 77.51% | |||
| Income Before Tax | 0.00% | 77.48% | |||
| Income Tax Expenses | 0.00% | -43.13% | |||
| Earnings from Continuing Operations | 0.00% | 77.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 77.17% | |||
| EBIT | 0.00% | 77.51% | |||
| EBITDA | 0.00% | 77.97% | |||
| EPS Basic | 0.00% | 80.82% | |||
| Normalized Basic EPS | 0.00% | 81.08% | |||
| EPS Diluted | 0.00% | 80.81% | |||
| Normalized Diluted EPS | 0.00% | 81.08% | |||
| Average Basic Shares Outstanding | 0.00% | 19.03% | |||
| Average Diluted Shares Outstanding | 0.00% | 19.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||